Clinical Trial Update: Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Relugolix with estradiol and norethindrone acetate for heavy menstrual bleeding due to uterine fibroids has completed and posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Relugolix with Estradiol and Norethindrone Acetate

Snippet

Sponsor: Myovant Sciences GmbH | Conditions: Uterine Leiomyoma, Uterine Fibroids | Phase 3 | Status: COMPLETED | Results posted: 2024-06-25